Large PBMs Control 70% of the Market: The Dominance of Major Players
Large PBMs and Their Market Dominance
Large PBMs control an astonishing 70% of the U.S. prescription market, raising crucial questions about healthcare accessibility and affordability. Among these, CVS Health stands out as the largest, commanding a remarkable 21.3% market share.
Key Players in the PBM Landscape
- CVS Health - 21.3% market share
- OptumRx - 20.8% market share
- Express Scripts - 17.1% market share
- Prime Therapeutics - 10.3% market share
The domination of these large players affects not only pricing but also the availability of medications for patients across the country.
Implications of Market Concentration
Such concentration in the PBM market underscores the necessity for enhanced oversight and potential reforms to ensure that patients receive fair access to affordable medications.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.